Baker Hughes Sells Waygate to Hexagon for $1.45B, Sharpens Core Focus

What happened

Baker Hughes has agreed to sell its Waygate Technologies business to Hexagon for $1.45 billion, a divestiture that streamlines the company's portfolio toward its core energy and industrial technology segments. The sale of the non-destructive testing and industrial inspection unit aligns with management's strategic emphasis on IET (Industrial & Energy Technology) and the pending Chart Industries acquisition, while also providing additional liquidity. Although the transaction represents a relatively small portion of Baker Hughes' overall revenue, it underscores a disciplined approach to capital allocation by shedding peripheral assets to prioritize higher-growth, higher-margin areas. Proceeds from the sale could help fund the $13.6 billion Chart deal or reduce leverage, which is critical given the company's pro forma net debt expectations following that acquisition. The market reaction is likely to be muted, as the divestiture was widely anticipated and does little to address the core concerns around elevated valuation, OFSE cyclicality, and integration risk from Chart.

Implication

Investors should view the $1.45 billion Waygate sale as a modest step toward a cleaner, more focused energy technology company, which may be incrementally positive for long-term margins and capital efficiency. However, the transaction is small relative to Baker Hughes' ~$56 billion market cap and $27+ billion revenue base, so it does not move the needle on the core investment thesis of IET growth and OFSE recovery. The sale proceeds, equivalent to roughly 10% of the Chart acquisition price, could modestly reduce the need for additional debt, but pro forma leverage will still rise meaningfully after Chart closes. Given the stock currently trades at ~21x EPS and consensus targets remain clustered in the mid-$50s, the risk-reward remains skewed to the downside if LNG orders or Chart synergies disappoint. Consequently, the existing POTENTIAL SELL rating and trim-above-$65 discipline remain appropriate; the asset sale is not a catalyst to change the stand, though it may support a floor near the $48 attractive entry if the market rewards portfolio quality.

Thesis delta

The sale of Waygate is consistent with Baker Hughes' ongoing portfolio rationalization and does not change the fundamental investment case. It marginally improves the balance sheet and focus, but the core risks of high valuation, cyclical OFSE weakness, and integration risk from the Chart acquisition remain. Thus, the thesis remains a hold-or-trim stance with no change to the price targets.